EGFR AND HER-2/NEU EVALUATION IN PATIENTS WITH RECURRENT NSCLC TREATED WITH ZD1839 (IRESSA) ON A COMPASSIONATE USE PROTOCOL


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles